SB139
To Require That The Arkansas Medicaid Program Cover Authorized Prescription Digital Therapeutics.
Last Action (May 1, 2023): Sine Die adjournment
Sponsors
AI-Generated Summary
Senate Bill 139 mandates that the Arkansas Medicaid program provide coverage for FDA-authorized prescription digital therapeutics intended to treat substance and opioid use disorders. The bill defines these therapeutics as medical products, devices, or applications that utilize cognitive behavioral therapy and contingency management and require a prescription. The legislative findings state that this initiative aims to combat the state's opioid epidemic by expanding access to evidence-based treatments. It asserts that digital therapeutics offer a cost-neutral alternative to traditional treatment methods. The bill requires that such treatments be covered for individuals when deemed appropriate by a licensed provider. It specifically targets technology that has been cleared or approved by the U.S. Food and Drug Administration.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries include Arkansas Medicaid recipients suffering from substance or opioid use disorders, who would gain access to digital, evidence-based treatment options. Licensed healthcare providers also benefit by having an additional, state-covered tool to prescribe for patients. Furthermore, the state of Arkansas may benefit from potentially lower long-term costs associated with untreated addiction and the improvement of public health outcomes related to the opioid epidemic.
Who Might Suffer?
The primary entity potentially negatively impacted is the Arkansas Medicaid budget, which would be required to fund these new services, although the bill anticipates the mandate will remain cost-neutral. Additionally, traditional healthcare providers or facilities that rely solely on in-person, non-digital treatment models could potentially face increased competition or shifts in patient referral patterns if digital therapeutics become a preferred or required first-line treatment.
Get Notified
Receive an email when this bill's status changes.